BioCentury
ARTICLE | Distillery Therapeutics

Cancer

February 8, 2017 3:50 PM UTC

In vitro studies suggest inhibiting DNM2 could help treat metastatic bladder cancer. In a human bladder cancer cell line, a DNM2 inhibitor tool compound or siRNA targeting DNM2 decreased formation of ...

BCIQ Target Profiles

Dynamin 2 (DNM2)